Home Medical stocks Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.’s (HKG:1501) 1.0% Yield

Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.’s (HKG:1501) 1.0% Yield

47
0

Today we’ll take a closer look at Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501) from a dividend investor’s perspective. Owning a strong business and reinvesting the dividends is widely seen as an attractive way of growing your wealth. If you are hoping to live on the income from dividends, it’s important to be a lot more stringent with your investments than the average punter.

Some readers mightn’t know much about Shanghai Kindly Medical Instruments’s 1.0% dividend, as it has only been paying distributions for a year or so. There are a few simple ways to reduce the risks of buying Shanghai Kindly Medical Instruments for its dividend, and we’ll go through these below.

Click the interactive chart for our full dividend analysis

SEHK:1501 Historic Dividend April 5th 2021

Payout ratios

Companies (usually) pay dividends out of their earnings. If a company is paying more than it earns, the dividend might have to be cut. As a result, we should always investigate whether a company can afford its dividend, measured as a percentage of a company’s net income after tax. In the last year, Shanghai Kindly Medical Instruments paid out 39% of its profit as dividends. A medium payout ratio strikes a good balance between paying dividends, and keeping enough back to invest in the business. Plus, there is room to increase the payout ratio over time.

While the above analysis focuses on dividends relative to a company’s earnings, we do note Shanghai Kindly Medical Instruments’ strong net cash position, which will let it pay larger dividends for a time, should it choose.

Consider getting our latest analysis on Shanghai Kindly Medical Instruments’ financial position here.

Dividend Volatility

One of the major risks of relying on dividend income, is the potential for a company to struggle financially and cut its dividend. Not only is your income cut, but the value of your investment declines as well – nasty. This company has been paying a dividend for less than 2 years, which we think is too soon to consider it a reliable dividend stock. This works out to be a compound annual growth rate (CAGR) of approximately 63% a year over that time.

The dividend has been growing pretty quickly, which could be enough to get us interested even though the dividend history is relatively short. Further research may be warranted.

Dividend Growth Potential

Examining whether the dividend is affordable and stable is important. However, it’s also important to assess if earnings per share (EPS) are growing. Over the long term, dividends need to grow at or above the rate of inflation, in order to maintain the recipient’s purchasing power. Strong earnings per share (EPS) growth might encourage our interest in the company despite fluctuating dividends, which is why it’s great to see Shanghai Kindly Medical Instruments has grown its earnings per share at 13% per annum over the past five years. Earnings per share have been growing at a good rate, and the company is paying less than half its earnings as dividends. We generally think this is an attractive combination, as it permits further reinvestment in the business.

We’d also point out that Shanghai Kindly Medical Instruments issued a meaningful number of new shares in the past year. Trying to grow the dividend when issuing new shares reminds us of the ancient Greek tale of Sisyphus – perpetually pushing a boulder uphill. Companies that consistently issue new shares are often suboptimal from a dividend perspective.

Conclusion

Dividend investors should always want to know if a) a company’s dividends are affordable, b) if there is a track record of consistent payments, and c) if the dividend is capable of growing. We’re glad to see Shanghai Kindly Medical Instruments has a low payout ratio, as this suggests earnings are being reinvested in the business. Next, earnings growth has been good, but unfortunately the company has not been paying dividends as long as we’d like. Shanghai Kindly Medical Instruments has a credible record on several fronts, but falls slightly short of our standards for a dividend stock.

It’s important to note that companies having a consistent dividend policy will generate greater investor confidence than those having an erratic one. Still, investors need to consider a host of other factors, apart from dividend payments, when analysing a company. For instance, we’ve picked out 1 warning sign for Shanghai Kindly Medical Instruments that investors should take into consideration.

Looking for more high-yielding dividend ideas? Try our curated list of dividend stocks with a yield above 3%.

Promoted
If you decide to trade Shanghai Kindly Medical Instruments, use the lowest-cost* platform that is rated #1 Overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

https://simplywall.st/stocks/hk/healthcare/hkg-1501/shanghai-kindly-medical-instruments-shares/news/shareholders-are-loving-shanghai-kindly-medical-instruments
https://simplywall.st/stocks/hk/healthcare/hkg-1501/shanghai-kindly-medical-instruments-shares/news/shareholders-are-loving-shanghai-kindly-medical-instruments

This site uses Akismet to reduce spam. Learn how your comment data is processed.